IP Library › Granted Patent US 12,285,626
Granted Patent B2
US 12,285,626 · App. 18/108,959 · Granted Apr 29, 2025

Lighting system for protecting circadian neuroendocrine function

Inventors: Martin Christopher Moore-Ede (Wellesley, MA); Rebecca Mary Chacko (Brookline, MA); Anneke Marlies Heitmann (Arlington, MA); Robert Frederic Casper (Toronto, CA); Robert Frank Karlicek, Jr. (Clifton, NY); Doros Platika (Pittsburgh, PA); Udo Trutschel (Tabarz, DE)
Assignee: KORRUS, INC.
A61N5/0618A61M21/00A61N5/062C09K11/592C09K11/621H05B45/20H05B47/155H05B47/16A61M2021/0005A61M2021/0044A61M2021/0083A61M2205/3368A61M2205/50A61N2005/0629A61N2005/063A61N2005/0636A61N2005/065A61N2005/0651A61N2005/0652A61N2005/0653A61N2005/0654A61N2005/0658A61N2005/0663F21K9/20F21V9/08F21V14/08F21Y2105/00F21Y2115/10F21Y2115/15Y02B20/00Y02B20/30Y02B20/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,285,626
App. No.
18/108,959
Granted
Apr 29, 2025
Kind
B2
Abstract

Lighting systems, methods, and devices for protecting human circadian neuroendocrine function during night use are described. Suitable lighting conditions can be provided for a working environment while protecting the circadian neuroendocrine systems of those occupying the illuminated workplace during the night. Lighting systems, methods, and devices can provide substantive attenuation of the pathologic circadian disruption in night workers. Lighting systems, methods, and devices can attenuate the specific bands of light implicated in circadian disruption. LED lighting systems, methods, and devices can provide increased intensity at a different portion of the spectrum than conventional LEDs, providing a useable white light even when unfavorable portions of the wavelength are attenuated by a notch filter. LED lighting systems, methods, and devices can switch between a daytime configuration and a night time configuration, wherein the daytime configuration provides unfiltered light and the night time configuration provides filtered light.

Claims (32)

1. A device, comprising:

a display configured to emit light; and

a device controller configured to cause the display to emit one or more modes of white light, each mode having a total spectral power in a wavelength range from 400 nm to 700 nm, a first component wavelength range from 400 nm to 430 nm, a second component wavelength range from 430 nm to 500 nm, and a third component wavelength range from 500 nm to 700 nm; and

wherein said one or more modes of white light comprises a first mode wherein greater than four percent (4%) of the total spectral power of said first mode is in said first component wavelength band, and wherein less than six percent (6%) of the total spectral power of said first mode is in said second component wavelength band.

2. The device of claim 1 , wherein the display is a liquid crystal display.

3. The device of claim 1 , wherein the display is a plasma display.

4. The device of claim 1 , wherein the device is a computer display or a television.

5. The device of claim 1 , wherein the device is a phone, a tablet or a laptop computer.

6. The device of claim 1 , wherein the device comprises one or more light emitting diodes (LEDs) and/or organic light emitting diodes (OLEDs).

7. A device, comprising:

at least one violet light emitting diode (LED);

at least one blue LED;

at least one green LED;

at least one red LED;

a device controller configured to control light emission from the at least one violet LED, at least one blue LED, at least one green LED, and at least one red LED to emit one or more modes of white light, each mode having a total spectral power in a wavelength range from 400 nm to 700 nm, a first component wavelength range from 400 nm to 430 nm, a second component wavelength range from 430 nm to 500 nm, and a third component wavelength range from 500 nm to 700 nm:

wherein said one or more modes of white light comprises a first mode wherein greater than four percent (4%) of the total spectral power of said first mode is in said first component wavelength band, and wherein less than six percent (6%) of the total spectral power of said first mode is in said second component wavelength band.

8. The device of claim 7 , wherein the device comprises a LED array comprising the at least one violet LED, at least one blue LED, at least one green LED, and at least one red LED.

9. A method, comprising:

emitting one or more modes of white light from a display,

each mode having a total spectral power in a wavelength range from 400 nm to 700 nm, a first component wavelength range from 400 nm to 430 nm, a second component wavelength range from 430 nm to 500 nm, and a third component wavelength range from 500 nm to 700 nm:

wherein said one or more modes of white light comprises a first mode wherein greater than four percent (4%) of the total spectral power of said first mode is in said first component wavelength band, and wherein less than six percent (6%) of the total spectral power of said first mode is in said second component wavelength band.

10. The method of claim 9 , wherein the display comprises at least a first light emitting diode (LED) configured to emit light having an intensity peak in the first component wavelength band.

11. The method of claim 10 , wherein the display further comprises at least a second LED configured to emit light having an intensity peak in the second component wavelength band and the controller is programmed to vary a relative intensity of the first and second LEDs according to the circadian cycle.

12. The device of claim 1 , wherein less than one percent (1%) of the total spectral power of said first mode is in said second component wavelength band.

13. The device of claim 1 , wherein greater than then ten percent (10%) of the total spectral power of said first mode is in said first component wavelength band.

14. The device of claim 1 , wherein said one or more modes of white light comprises a second mode wherein greater than ten percent (10%) of the total spectral power in said second mode is in the second component wavelength band.

15. The device of claim 14 , wherein said first mode is a night mode and said second mode is a day mode.

16. The device of claim 14 , wherein said device controller is configured to switch between said first and second modes automatically.

17. The device of claim 16 , wherein said device controller is configured to switch between said first and second modes automatically based on predetermined circadian-phase or time of day instructions.

18. The device of claim 17 , wherein said predetermined circadian-phase or time of day instructions comprises at least one of seasonal adjusted times, instructions including fixed clock times, and instructions including times chosen by a user.

19. The device of claim 7 , wherein less than one percent (1%) of the total spectral power of said first mode is in said second component wavelength band.

20. The device of claim 7 , wherein said one or more modes of white light comprises a second mode wherein greater than ten percent (10%) of the total spectral power in said second mode is in the second component wavelength band.

Continuity (6)
Continuation 16986123 · Aug 5, 2020
Continuation 15669846 · Aug 4, 2017
Continuation 14874601 · Oct 5, 2015
Continuation PCTUS2014032858 · Apr 3, 2014
Provisional Application 61808584 · Apr 4, 2013
Related Publication 20230233872A1 · Jul 27, 2023
References Cited (105)
US 7520607B2 · Casper · 2009 [cited by applicant]
US 7678140B2 · Brainard · 2010 [cited by applicant]
US 7748845B2 · Casper · 2010 [cited by applicant]
US 9827440B2 · Moore-Ede · 2017 [cited by applicant]
US 20040230252A1 · Kullok · 2004 [cited by applicant]
US 20100063566A1 · Uchiumi · 2010 [cited by applicant]
US 20100121420A1 · Fiset · 2010 [cited by applicant]
US 20100179469A1 · Hammond · 2010 [cited by applicant]
US 20100244740A1 · Alpert · 2010 [cited by applicant]
US 20110299277A1 · Ehara · 2011 [cited by applicant]
US 20120008326A1 · Jou · 2012 [cited by applicant]
US 20120069551A1 · Bues · 2012 [cited by applicant]
US 20120167693A1 · Asao · 2012 [cited by applicant]
US 20120175588A1 · Qiao · 2012 [cited by applicant]
US 20120200234A1 · Godlieb · 2012 [cited by applicant]
US 20120271384A1 · Muehlemann · 2012 [cited by applicant]
US 20130006118A1 · Pan · 2013 [cited by applicant]
US 20140217417A1 · Horie · 2014 [cited by applicant]
US 20140217902A1 · Maxik · 2014 [cited by applicant]
US 20140243935A1 · Brainard · 2014 [cited by applicant]
US 20140306620A1 · Maxik · 2014 [cited by applicant]
US 20150102749A1 · Soler · 2015 [cited by applicant]
US 20150342457A1 · Sanchez Ramos · 2015 [cited by applicant]
US 20160243379A1 · Hommes · 2016 [cited by applicant]
US 20170326380A1 · Moore-Ede · 2017 [cited by applicant]
CN 101589652 · 2009 [cited by applicant]
CN 101678209 · 2010 [cited by applicant]
CN 101681330 · 2010 [cited by applicant]
CN 102596302 · 2012 [cited by applicant]
CN 102966899 · 2013 [cited by applicant]
CN 105992612 · 2016 [cited by applicant]
EP 1285676A2 · 2003 [cited by applicant]
EP 2386329A1 · 2011 [cited by applicant]
EP 2493541A2 · 2012 [cited by applicant]
JP 2007044201 · 2007 [cited by applicant]
JP 2009259639 · 2009 [cited by applicant]
JP 2011258649 · 2011 [cited by applicant]
JP 2012064860 · 2012 [cited by applicant]
WO 2000077547 · 2000 [cited by applicant]
WO 2008069101A1 · 2008 [cited by applicant]
WO 2012110178 · 2012 [cited by applicant]
WO 2013184627 · 2013 [cited by applicant]
WO 2014165692 · 2014 [cited by applicant]
Bailes, H. J. and R. J. Lucas. 2013. “Human Melanopsin Forms a Pigment Maximally Sensitive to Blue Light (Lambdamax Approximately 479 Nm) Supporting Activation of G(Q/11) and G(i/O) Signaling Cascades.” Proceedings. Bio… [cited by applicant]
Beaven et al., “A Comparison of Blue Light and Caffeine Effects on Cognitive Function and Alertness in Humans,” PLOS One, Oct. 2013, vol. 8, Issue 10, 7 pages. [cited by applicant]
Berson, D. M., F. A. Dunn, and M. Takao. 2002. “Phototransduction by Retinal Ganglion Cells that Set the Circadian Clock.” Science 295: 1070-1073. [cited by applicant]
Brainard, G. C., D. Sliney, J.P. Hanifin, G. Glickman, B. Byrne, J.M. Greeson, S. Jasser, E. Gerner, and M. D. Rollag. 2008. “Sensitivity of the Human Circadian System to Short-Wavelength (420-Nm) Light.” Journal of Bio… [cited by applicant]
Brainard, G. C., J.P. Hanifin, J.M. Greeson, B. Byrne, G. Glickman, E. Gerner, and M. D. Rollag. 2001a. “Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor.” The Journal of … [cited by applicant]
Brainard, G. C., J.P. Hanifin, M. D. Rollag, J. Greeson, B. Byrne, G. Glickman, E. Gerner, and B. Sanford. 2001b. “Human Melatonin Regulation is Not Mediated by the Three Cone Photopic-Visual System.” Journal of Clinica… [cited by applicant]
Cajochen, C., C. Jud, M. Munch, S. Kobialka, A. Wirz-Justice, and U. Albrecht. 2006. “Evening Exposure to Blue Light Stimulates the Expression of the Clock Gene PER2 in Humans.” The European Journal of Neuroscience 23 (… [cited by applicant]
Cajochen, C., M. Munch, S. Kobialka, K. Krauchi, R. Steiner, P. Oelhafen, S. Orgul, and A.Wirz-Justice. 2005. “High Sensitivity of Human Melatonin, Alertness, Thermoregulation, and Heart Rate to Short Wavelength Light.”… [cited by applicant]
Chinese Patent Office, Notice of Issuance of Patent Application No. 201480032189.0 dated May 27, 2017 (machine translation), 3 pages. [cited by applicant]
EP Examination Report in European Application No. 16 762 412.1, dated Mar. 1, 2021, 7 pages. [cited by applicant]
Japanese Patent Office, Office Action mailed Dec. 13, 2017 for JP Application No. 2016-506622, including English translation of notice of reason for rejection, 13 pages. [cited by applicant]
Notice of Reason for Rejection, Japanese Patent Application No. 2018-154517, mailed Jul. 10, 2019 (English translation included), 19 pages. [cited by applicant]
Office Action for Japanese Patent Application No. 2016-506622, mailed Mar. 23, 2018, with English translation of Notice of Reason for Rejection, 8 pages. [cited by applicant]
Extended European Search Report, dated Jan. 31, 2019, for EP Application No. 18201950.5, 10 pages. [cited by applicant]
Partial Supplementary European Search Report (R. 164 EPC) dated Oct. 13, 2016 for EP application No. 14778506.7, 8 pages. [cited by applicant]
Supplementary European Search Report and Written Opinion (R. 62 EPC) dated Jan. 30, 2017 for EP application No. 14778506.7, 14 pages. [cited by applicant]
The State Intellectual Property Office of the People's Republic of China, office action mailed Dec. 2, 2016 for CN patent application No. 2014800321890, including English translation, 10 pages. [cited by applicant]
Office Action for Korean Patent Application No. 10-2015-7031686, mailed Mar. 13, 2018, with English translation, 19 pages. [cited by applicant]
Figueiro, M. G., M. S. Rea, and J. D. Bullough. 2006. “Circadian Effectiveness of Two Polychromatic Lights in Suppressing Human Nocturnal Melatonin.” Neurosci Lett 406 (3): 293-7. [cited by applicant]
Francis, G., L. Bishop, C. Luke, B. Middleton, P. Williams, and J. Arendt. 2008. “Sleep during the Antarctic Winter: Preliminary Observations on Changing the Spectral Composition of Artificial Light.” Journal of Sleep R… [cited by applicant]
Gamlin, P. D., D. H. McDougal, J. Pokorny, V. C. Smith, K. W. Yau, and D. M. Dacey. 2007. “Human and Macaque Pupil Responses Driven by Melanopsin-Containing Retinal Ganglion Cells.” Vision Res 47 (7): 946-54. [cited by applicant]
Gooley, J. J., J. Lu, D. Fischer, and C. B. Saper. 2003. “A Broad Role for Melanopsin in Nonvisual Photo reception.” Journal of Neuroscience 23: 7093-7106. [cited by applicant]
Gooley, J. J., K. Chamberlain, K. A. Smith, S. B. Khalsa, S. M. Rajaratnam, E. Van Reen, J.M. Zeitzer, C. A. Czeisler, and S. W. Lockley. 2011. “Exposure to Room Light before Bedtime Suppresses Melatonin Onset and Short… [cited by applicant]
Gooley, J. J., S. M. Rajaratnam, G. C. Brainard, R. E. Kronauer, C. A. Czeisler, and S. W. Lockley. 2010. “Spectral Responses of the Human Circadian System Depend on the Irradiance and Duration of Exposure to Light.” Sc… [cited by applicant]
Hattar, S., H. W. Liao, M. Takao, D. M. Berson, and K. W. Yau. 2002. “Melanopsin-Containing Retinal Ganglion Cells: Architecture, Projections, and Intrinsic Photo sensitivity.” Science 295: 1065-1070. [cited by applicant]
IN Examination Report in India Application No. 10190/DELNP/2015, dated Aug. 21, 2020, 11 pages. [cited by applicant]
International Search Report and Written Opinion Issued in PCT/US14/032858, dated Aug. 25, 2014. [cited by applicant]
Kayumov, L., R. F. Casper, R. J. Hawa, B. Perelman, S. A. Chung, S. Sokalsky, and C. M. Shapiro. 2005. “Blocking Low-Wavelength Light Prevents Nocturnal Melatonin Suppression with no Adverse Effect on Performance during… [cited by applicant]
Kozaki, T., S. Koga, N. Toda, H. Noguchi, and A. Yasukouchi. 2008. “Effects of Short Wavelength Control in Polychromatic Light Sources on Nocturnal Melatonin Secretion.” Neuroscience Letters 439 (3): 256-9. [cited by applicant]
Krames, M. Light-Emitting Diodes: GaN-on-GaN platform removes cost/performance tradeoffs in LED lighting. LaserFocusWorld. Published Sep. 16, 2013. Retrieved Jan. 2020. Retrieved from the Internet URL<https://digital.la… [cited by applicant]
Lin, J. Shuji Nakamura: GaN-on-GaN Will Become the Next Generation LED Technology. LEDinside. Published Apr. 9, 2015. Retrieved Jan. 2020. Retrieved from the Internet: URL<https://www.ledinside.com/interview/2015/4/shuj… [cited by applicant]
Lockley, S. W., E. E. Evans, F. A. Scheer, G. C. Brainard, C. A. Czeisler, and D. Aeschbach. 2006. “Short-Wavelength Sensitivity for the Direct Effects of Light on Alertness, Vigilance, and the Waking Electroencephalogr… [cited by applicant]
Lockley, S. W., G. C. Brainard, and C. A Czeisler. 2003. “High Sensitivity of the Human CI8 Circadian Melatonin Rhythm to Resetting by Short Wavelength Light.” The Journal of Clinical Endocrinolozy and Metabolism 88 (9)… [cited by applicant]
Mills, P.R., S. C. Tomkins, and L. J. Schlangen. 2007. “The Effect of High Correlated Colour Temperature Office Lighting on Employee Wellbeing and Work Performance.” Journal of Circadian Rhythms 5: 2. [cited by applicant]
Moore-Ede et al., “Circadian Light LED Fixtures Present Insulin Resistance Caused by Exposure to Conventional LED Light at Night”, Abstract submitted to Light, Health and Wellbeing Conference, 2017. [cited by applicant]
Mottram, V., B. Middleton, P. Williams, and J. Arendt. 2011. “The Impact of Bright Artificial White and ‘Blue-Enriched’ Light on Sleep and Circadian Phase during the Polar Winter.” Journal of Sleep Research 20 (1 Pt2): … [cited by applicant]
Munch, M., S. Kobialka, R. Steiner, P. Oelhafen, A. Wirz-Justice, and C. Cajochen. 2006. “Wave length-Dependent Effects of Evening Light Exposure on Sleep Architecture and Sleep EEG Power Density in Men.” American Journ… [cited by applicant]
Nakamura, S. et al. History of Gallium-Nitride-Based Light-Emitting Diodes for Illumination. Proceedings of the IEEE, vol. 101, No. 10. Published Oct. 2013. 10 pages. [cited by applicant]
Office Action received in Canadian Patent Application No. 2,908,659. Dated Jun. 8, 2020. 7 pages. [cited by applicant]
Office Action received in Chinese Patent Application No. 201710683301.2. Dated May 20, 2020. 10 pages. Translation included. [cited by applicant]
Office Action received in Chinese Patent Application No. 201710683301.2. Dated Nov. 8, 2019. 22 pages. Translation included. [cited by applicant]
Panda, S., I. Provencio, D. C. Tu, S.S. Pires, M. D. Rollag, A. M. Castmcci, M. T. Pletcher, et al. 2003. “Melanopsin is Required for Non-Image-Forming Photic Responses in Blind Mice.” Science 301: 525-527. [cited by applicant]
Panda, S., S. K. Nayak, B. Camp, J. R. Walker, J.B. Hogenesch, and T. Jegla. 2005. “Illumination of the Melanopsin Signaling Pathway.” Science 307: 600-604. [cited by applicant]
Panda, S., T. K. Sato, A. M. Castmcci, M. D. Rollag, W. J. DeGrip, J.B. Hogenesch, I. Provencio, and S. A. Kay. 2002. “Melanopsin (Opn4) Requirement for Normal Light-Induced Circadian Phase Shifting.” Science 298: 2213-… [cited by applicant]
PHILIPS LUMILEDS, LUXEON Rebel PC Amber Technical Datasheet, 2010, PHILIPS, pp. 1-22. [cited by applicant]
Program for Transforming Healthcare and Well Being Through Lighting, Illuminating Engineering Society (IES), Annual Meeting, Oct. 22-23, 2016, organized by the Renssalaer Polytechnic Institute (PRI) Lighting Enabled Sys… [cited by applicant]
Qiu, X., T. Kumbalasiri, S. M. Carlson, K. Y. Wong, V. Krishna, I. Provencio, and D. M. Berson. 2005. “Induction of Photosensitivity by Heterologous Expression of Melanopsin.” Nature 433: 745-749. [cited by applicant]
Rahman, S. A., S. Marcu, C. M. Shapiro, T. J. Brown, and R. F. Casper. 2011. “Spectral Modulation Attenuates Molecular, Endocrine, and Neurobehavioral Disruption Induced by Nocturnal Light Exposure.” American Journal of… [cited by applicant]
Revell, V. L., J. Arendt, L. F. Fogg, and D. J. Skene. 2006. “Alerting Effects of Light are Sensitive to very Short Wavelengths.” Neuroscience Letters 399 (1-2): 96-100. [cited by applicant]
Revell, V. L., J. Arendt, M. Terman, and D. J. Skene. 2005. “Short-Wavelength Sensitivity of the Human Circadian System to Phase-Advancing Light.” Journal of Biological Rhythms 20:270-272. [cited by applicant]
Sasseville, A., D. Benhaberou-Bmn, C. Fontaine, M. C. Charon, and M. Hebert. 2009.“Wearing Blue-Blockers in the Morning could Improve Sleep of Workers on a Permanent Night Schedule: A Pilot Study.” Chronobiology Interna… [cited by applicant]
Sasseville, A., N. Paquet, J. Sevigny, and M. Hebert. 2006. “Blue Blocker Glasses Impede the Capacity of Bright Lightto Suppress Melatonin Production.” Journal of Pineal Research 41 (1): 73-78. [cited by applicant]
Scheer, et al., “Short-Wavelength Sensitivity for the Direct Effects of Light on Alertness, Vigilance, and the Waking . . . ” Sleep, Mar. 2006, 9 pages. [cited by applicant]
Shadab A. Rahman, Shai Marcu, Colin M. Shapiro, Theodore J. Brown, Robert F. Casper. Spectral modulation attenuates molecular, endocrine, and neurobehavioral disruption induced by nocturnal light exposure. Am J Phvsicol… [cited by applicant]
Straif, K., R. Baan, Y. Grosse, B. Secretan, F. El Ghissassi, Bouvard V, A. Altieri, L. Benbrahim-Tallaa, and Cogliano V. 2007. “Carcinogenicity of Shift-Work, Painting, and Fire-Fighting.” The Lancet Oncolor;zv 8: 1065… [cited by applicant]
Thapan, K., J. Arendt, and D. J. Skene. 2001. “An Action Spectrum for Melatonin Suppression: Evidence for a Novel Non-Rod, Non-Cone Photoreceptor System in Humans.” The Journal of Physiology 535 (Pt 1): 261-267. [cited by applicant]
Viola, A. U., L. M. James, L. J. Schlangen, and D. J. Dijk. 2008. “Blue-Enriched White Light in the Workplace Improves Self-Reported Alertness, Performance and Sleep Quality.” Scandinavian Journal of Work, Environment &… [cited by applicant]
Warman, V. L., D. J. Dijk, G. R. Warman, J. Arendt, and D. J. Skene. 2003. “Phase Advancing Human Circadian Rhythms with Short Wavelength Light.” Neuroscience Letters 342 (1-2): 37-40. [cited by applicant]
Wood, B., M. S. Rea, B. Plitnick, and M. G. Figueiro. 2013. “Light Level and Duration of Exposure Determine the Impact of Self-Luminous Tablets on Melatonin Suppression.” Applied Ergonomics 44 (2): 237-240. [cited by applicant]
Wright, H. R. and L. C. Lack. 2001. “Effect of Light Wavelength on Suppression and Phase Delay of the Melatonin Rhythm.” Chronobiology International 18 (5): 801-808. [cited by applicant]
Wright, H. R., L. C. Lack, and D. J. Kennaway. 2004. “Differential Effects of Light C38 Wavelength in Phase Advancing the Melatonin Rhythm.” Journal of Pineal Research 36: 140-144. [cited by applicant]
Wright, H. R., L. C. Lack, and K. J. Partridge. 2001. “Light Emitting Diodes can be used to Phase Delay the Melatonin Rhythm.” Journal of Pineal Research 31: 350-355. [cited by applicant]